Moderna, Inc. Reports Q2 2026 Financial Results

What Happened

• Moderna, Inc. announced its financial results for the quarter ended June 30, 2026 via a press release dated July 31, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8-K filed the same day (Item 2.02). The Form 8-K states the furnished information is not being “filed” for purposes of Section 18 of the Exchange Act.

Key Details

• Press release date: July 31, 2026.
• Reporting period: Quarter ended June 30, 2026 (Q2 2026).
• Exhibit included: 99.1 (press release); the filing also references the Inline XBRL cover page (Exhibit 104).
• Form 8-K signed by CFO James M. Mock on July 31, 2026.

Why It Matters

• The filing notifies investors that Moderna has released its quarterly earnings information; investors should read the press release (Exhibit 99.1) for revenue, earnings, guidance, and other financial details that can affect the stock.
• The company’s statement that the release is “furnished” (not “filed”) affects legal treatment under the Exchange Act but does not change the substance of the disclosed results.